ICM
ISZO Capital Management Portfolio holdings
AUM
$2M
This Quarter Return
-14.3%
1 Year Return
+35.61%
3 Year Return
+68.17%
5 Year Return
+471.86%
10 Year Return
–
AUM
$227M
AUM Growth
+$227M
(-18%)
Cap. Flow
-$16.1M
Cap. Flow
% of AUM
-7.12%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
11
New
3
Increased
2
Reduced
–
Closed
4
Top Buys
Top Sells
| 1 |
DMTK
DermTech, Inc. Common Stock
DMTK
|
$45.3M |
| 2 |
Anterix
ATEX
|
$7.58M |
| 3 |
Protagonist Therapeutics
PTGX
|
$4.21M |
| 4 |
CHS
Chicos FAS, Inc.
CHS
|
$136K |
Sector Composition
| 1 | Real Estate | 60.43% |
| 2 | Healthcare | 35.87% |
| 3 | Consumer Discretionary | 3.48% |
| 4 | Technology | 0.22% |
| 5 | Communication Services | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NTP
1
DELISTED
Nam Tai Property Inc.
NTP
| $137M | 60.43% | 5,891,377 +761,787 | +15% | +$17.7M |
|
|
CDMO
2
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $50.6M | 22.33% | 2,346,961 | – | – |
|
3
Lifecore Biomedical
LFCR
$285M
| $15.2M | 6.71% | +1,648,520 | New | +$15.2M |
|
4
Inotiv
NOTV
$58.1M
| $9.48M | 4.18% | 324,129 +57,249 | +21% | +$1.67M |
|
5
XPEL
XPEL
$1.03B
| $7.88M | 3.48% | 103,860 | – | – |
|
6
Cryo-Cell International
CCEL
$37.9M
| $6.01M | 2.65% | +496,503 | New | +$6.01M |
|
|
MTBL
7
DELISTED
Moatable, Inc. American Depositary Share (each representing forty-five (45) Class A Ordinary Shares)
MTBL
| $506K | 0.22% | +36,384 | New | +$506K |
|
|
8
Anterix
ATEX
$445M
| – | – | -126,311 | Closed | -$7.58M |
|
|
9
Protagonist Therapeutics
PTGX
$3.67B
| – | – | -93,883 | Closed | -$4.21M |
|
|
DMTK
10
DELISTED
DermTech, Inc. Common Stock
DMTK
| – | – | -1,090,254 | Closed | -$45.3M |
|
|
CHS
11
DELISTED
Chicos FAS, Inc.
CHS
| – | – | -20,690 | Closed | -$136K |
|